Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancer

Activation of CDK2 in triple negative breast cancer (TNBC) can contribute to non-canonical phosphorylation of a TGFβ signaling component, Smad3, promoting cell proliferation and migration. Inhibition of CDK2 was shown to decrease breast cancer oncogenesis. Eribulin chemotherapy was used effectively...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Rao, Shreyas S., Stoehr, Jenna, Dokic, Danijela, Wan, Lei, Decker, Joseph T., Konopka, Kristine, Thomas, Alexandra L., Wu, Jia, Kaklamani, Virginia G., Shea, Lonnie D., Jeruss, Jacqueline S.
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2017
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5663565/
https://ncbi.nlm.nih.gov/pubmed/29137393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20202
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker